img

Global Human Insulin Drugs Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Insulin Drugs Market Insights, Forecast to 2034

Global Human Insulin Drugs market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Human Insulin Drugs industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Human Insulin Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Human Insulin Drugs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novo Nordisk
Sanofi
Eli Lilly
Biocon
Pfizer
Wockhardt
Julphar
Exir
Sedico
Segment by Type
Basal or Long-acting Insulins
Bolus or Fast-acting Insulins
Traditional Human Insulins
Combination Insulins
Biosimilar Insulins

Segment by Application


Hospital
Household

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Human Insulin Drugs plant distribution, commercial date of Human Insulin Drugs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Human Insulin Drugs introduction, etc. Human Insulin Drugs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Human Insulin Drugs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Human Insulin Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Human Insulin Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Basal or Long-acting Insulins
1.2.3 Bolus or Fast-acting Insulins
1.2.4 Traditional Human Insulins
1.2.5 Combination Insulins
1.2.6 Biosimilar Insulins
1.3 Market by Application
1.3.1 Global Human Insulin Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Household
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Human Insulin Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Human Insulin Drugs Revenue by Region
2.2.1 Global Human Insulin Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Human Insulin Drugs Revenue by Region (2018-2024)
2.2.3 Global Human Insulin Drugs Revenue by Region (2024-2029)
2.2.4 Global Human Insulin Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Human Insulin Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Human Insulin Drugs Sales by Region
2.4.1 Global Human Insulin Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Human Insulin Drugs Sales by Region (2018-2024)
2.4.3 Global Human Insulin Drugs Sales by Region (2024-2029)
2.4.4 Global Human Insulin Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Human Insulin Drugs Sales by Manufacturers
3.1.1 Global Human Insulin Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Human Insulin Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Insulin Drugs in 2022
3.2 Global Human Insulin Drugs Revenue by Manufacturers
3.2.1 Global Human Insulin Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Human Insulin Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Human Insulin Drugs Revenue in 2022
3.3 Global Key Players of Human Insulin Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Human Insulin Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Human Insulin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Human Insulin Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Human Insulin Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Human Insulin Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Human Insulin Drugs Sales by Type
4.1.1 Global Human Insulin Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Human Insulin Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Human Insulin Drugs Sales Market Share by Type (2018-2029)
4.2 Global Human Insulin Drugs Revenue by Type
4.2.1 Global Human Insulin Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Human Insulin Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Human Insulin Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Human Insulin Drugs Price by Type
4.3.1 Global Human Insulin Drugs Price by Type (2018-2024)
4.3.2 Global Human Insulin Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Human Insulin Drugs Sales by Application
5.1.1 Global Human Insulin Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Human Insulin Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Human Insulin Drugs Sales Market Share by Application (2018-2029)
5.2 Global Human Insulin Drugs Revenue by Application
5.2.1 Global Human Insulin Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Human Insulin Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Human Insulin Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Human Insulin Drugs Price by Application
5.3.1 Global Human Insulin Drugs Price by Application (2018-2024)
5.3.2 Global Human Insulin Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Human Insulin Drugs Market Size by Type
6.1.1 US & Canada Human Insulin Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Human Insulin Drugs Revenue by Type (2018-2029)
6.2 US & Canada Human Insulin Drugs Market Size by Application
6.2.1 US & Canada Human Insulin Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Human Insulin Drugs Revenue by Application (2018-2029)
6.3 US & Canada Human Insulin Drugs Market Size by Country
6.3.1 US & Canada Human Insulin Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Human Insulin Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Human Insulin Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Human Insulin Drugs Market Size by Type
7.1.1 Europe Human Insulin Drugs Sales by Type (2018-2029)
7.1.2 Europe Human Insulin Drugs Revenue by Type (2018-2029)
7.2 Europe Human Insulin Drugs Market Size by Application
7.2.1 Europe Human Insulin Drugs Sales by Application (2018-2029)
7.2.2 Europe Human Insulin Drugs Revenue by Application (2018-2029)
7.3 Europe Human Insulin Drugs Market Size by Country
7.3.1 Europe Human Insulin Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Human Insulin Drugs Sales by Country (2018-2029)
7.3.3 Europe Human Insulin Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Human Insulin Drugs Market Size
8.1.1 China Human Insulin Drugs Sales (2018-2029)
8.1.2 China Human Insulin Drugs Revenue (2018-2029)
8.2 China Human Insulin Drugs Market Size by Application
8.2.1 China Human Insulin Drugs Sales by Application (2018-2029)
8.2.2 China Human Insulin Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Human Insulin Drugs Market Size by Type
9.1.1 Asia Human Insulin Drugs Sales by Type (2018-2029)
9.1.2 Asia Human Insulin Drugs Revenue by Type (2018-2029)
9.2 Asia Human Insulin Drugs Market Size by Application
9.2.1 Asia Human Insulin Drugs Sales by Application (2018-2029)
9.2.2 Asia Human Insulin Drugs Revenue by Application (2018-2029)
9.3 Asia Human Insulin Drugs Sales by Region
9.3.1 Asia Human Insulin Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Human Insulin Drugs Revenue by Region (2018-2029)
9.3.3 Asia Human Insulin Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Human Insulin Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Human Insulin Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Human Insulin Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Human Insulin Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Human Insulin Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Human Insulin Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Human Insulin Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Human Insulin Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Human Insulin Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Human Insulin Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novo Nordisk
11.1.1 Novo Nordisk Company Information
11.1.2 Novo Nordisk Overview
11.1.3 Novo Nordisk Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novo Nordisk Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novo Nordisk Recent Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Overview
11.2.3 Sanofi Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Sanofi Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Sanofi Recent Developments
11.3 Eli Lilly
11.3.1 Eli Lilly Company Information
11.3.2 Eli Lilly Overview
11.3.3 Eli Lilly Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Eli Lilly Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly Recent Developments
11.4 Biocon
11.4.1 Biocon Company Information
11.4.2 Biocon Overview
11.4.3 Biocon Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Biocon Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Biocon Recent Developments
11.5 Pfizer
11.5.1 Pfizer Company Information
11.5.2 Pfizer Overview
11.5.3 Pfizer Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Pfizer Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Recent Developments
11.6 Wockhardt
11.6.1 Wockhardt Company Information
11.6.2 Wockhardt Overview
11.6.3 Wockhardt Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Wockhardt Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Wockhardt Recent Developments
11.7 Julphar
11.7.1 Julphar Company Information
11.7.2 Julphar Overview
11.7.3 Julphar Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Julphar Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Julphar Recent Developments
11.8 Exir
11.8.1 Exir Company Information
11.8.2 Exir Overview
11.8.3 Exir Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Exir Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Exir Recent Developments
11.9 Sedico
11.9.1 Sedico Company Information
11.9.2 Sedico Overview
11.9.3 Sedico Human Insulin Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Sedico Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Sedico Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Human Insulin Drugs Industry Chain Analysis
12.2 Human Insulin Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Human Insulin Drugs Production Mode & Process
12.4 Human Insulin Drugs Sales and Marketing
12.4.1 Human Insulin Drugs Sales Channels
12.4.2 Human Insulin Drugs Distributors
12.5 Human Insulin Drugs Customers
13 Market Dynamics
13.1 Human Insulin Drugs Industry Trends
13.2 Human Insulin Drugs Market Drivers
13.3 Human Insulin Drugs Market Challenges
13.4 Human Insulin Drugs Market Restraints
14 Key Findings in The Global Human Insulin Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Insulin Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Basal or Long-acting Insulins
Table 3. Major Manufacturers of Bolus or Fast-acting Insulins
Table 4. Major Manufacturers of Traditional Human Insulins
Table 5. Major Manufacturers of Combination Insulins
Table 6. Major Manufacturers of Biosimilar Insulins
Table 7. Global Human Insulin Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Human Insulin Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 9. Global Human Insulin Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 10. Global Human Insulin Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 11. Global Human Insulin Drugs Revenue Market Share by Region (2018-2024)
Table 12. Global Human Insulin Drugs Revenue Market Share by Region (2024-2029)
Table 13. Global Human Insulin Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 14. Global Human Insulin Drugs Sales by Region (2018-2024) & (K Units)
Table 15. Global Human Insulin Drugs Sales by Region (2024-2029) & (K Units)
Table 16. Global Human Insulin Drugs Sales Market Share by Region (2018-2024)
Table 17. Global Human Insulin Drugs Sales Market Share by Region (2024-2029)
Table 18. Global Human Insulin Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 19. Global Human Insulin Drugs Sales Share by Manufacturers (2018-2024)
Table 20. Global Human Insulin Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 21. Global Human Insulin Drugs Revenue Share by Manufacturers (2018-2024)
Table 22. Global Key Players of Human Insulin Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 23. Human Insulin Drugs Price by Manufacturers 2018-2024 (US$/Unit)
Table 24. Global Human Insulin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Human Insulin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin Drugs as of 2022)
Table 26. Global Key Manufacturers of Human Insulin Drugs, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Human Insulin Drugs, Product Offered and Application
Table 28. Global Key Manufacturers of Human Insulin Drugs, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Human Insulin Drugs Sales by Type (2018-2024) & (K Units)
Table 31. Global Human Insulin Drugs Sales by Type (2024-2029) & (K Units)
Table 32. Global Human Insulin Drugs Sales Share by Type (2018-2024)
Table 33. Global Human Insulin Drugs Sales Share by Type (2024-2029)
Table 34. Global Human Insulin Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 35. Global Human Insulin Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 36. Global Human Insulin Drugs Revenue Share by Type (2018-2024)
Table 37. Global Human Insulin Drugs Revenue Share by Type (2024-2029)
Table 38. Human Insulin Drugs Price by Type (2018-2024) & (US$/Unit)
Table 39. Global Human Insulin Drugs Price Forecast by Type (2024-2029) & (US$/Unit)
Table 40. Global Human Insulin Drugs Sales by Application (2018-2024) & (K Units)
Table 41. Global Human Insulin Drugs Sales by Application (2024-2029) & (K Units)
Table 42. Global Human Insulin Drugs Sales Share by Application (2018-2024)
Table 43. Global Human Insulin Drugs Sales Share by Application (2024-2029)
Table 44. Global Human Insulin Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 45. Global Human Insulin Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 46. Global Human Insulin Drugs Revenue Share by Application (2018-2024)
Table 47. Global Human Insulin Drugs Revenue Share by Application (2024-2029)
Table 48. Human Insulin Drugs Price by Application (2018-2024) & (US$/Unit)
Table 49. Global Human Insulin Drugs Price Forecast by Application (2024-2029) & (US$/Unit)
Table 50. US & Canada Human Insulin Drugs Sales by Type (2018-2024) & (K Units)
Table 51. US & Canada Human Insulin Drugs Sales by Type (2024-2029) & (K Units)
Table 52. US & Canada Human Insulin Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 53. US & Canada Human Insulin Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 54. US & Canada Human Insulin Drugs Sales by Application (2018-2024) & (K Units)
Table 55. US & Canada Human Insulin Drugs Sales by Application (2024-2029) & (K Units)
Table 56. US & Canada Human Insulin Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 57. US & Canada Human Insulin Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 58. US & Canada Human Insulin Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 59. US & Canada Human Insulin Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 60. US & Canada Human Insulin Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 61. US & Canada Human Insulin Drugs Sales by Country (2018-2024) & (K Units)
Table 62. US & Canada Human Insulin Drugs Sales by Country (2024-2029) & (K Units)
Table 63. Europe Human Insulin Drugs Sales by Type (2018-2024) & (K Units)
Table 64. Europe Human Insulin Drugs Sales by Type (2024-2029) & (K Units)
Table 65. Europe Human Insulin Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 66. Europe Human Insulin Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 67. Europe Human Insulin Drugs Sales by Application (2018-2024) & (K Units)
Table 68. Europe Human Insulin Drugs Sales by Application (2024-2029) & (K Units)
Table 69. Europe Human Insulin Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 70. Europe Human Insulin Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 71. Europe Human Insulin Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 72. Europe Human Insulin Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 73. Europe Human Insulin Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 74. Europe Human Insulin Drugs Sales by Country (2018-2024) & (K Units)
Table 75. Europe Human Insulin Drugs Sales by Country (2024-2029) & (K Units)
Table 76. China Human Insulin Drugs Sales by Type (2018-2024) & (K Units)
Table 77. China Human Insulin Drugs Sales by Type (2024-2029) & (K Units)
Table 78. China Human Insulin Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 79. China Human Insulin Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 80. China Human Insulin Drugs Sales by Application (2018-2024) & (K Units)
Table 81. China Human Insulin Drugs Sales by Application (2024-2029) & (K Units)
Table 82. China Human Insulin Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 83. China Human Insulin Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 84. Asia Human Insulin Drugs Sales by Type (2018-2024) & (K Units)
Table 85. Asia Human Insulin Drugs Sales by Type (2024-2029) & (K Units)
Table 86. Asia Human Insulin Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 87. Asia Human Insulin Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 88. Asia Human Insulin Drugs Sales by Application (2018-2024) & (K Units)
Table 89. Asia Human Insulin Drugs Sales by Application (2024-2029) & (K Units)
Table 90. Asia Human Insulin Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 91. Asia Human Insulin Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 92. Asia Human Insulin Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 93. Asia Human Insulin Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 94. Asia Human Insulin Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 95. Asia Human Insulin Drugs Sales by Region (2018-2024) & (K Units)
Table 96. Asia Human Insulin Drugs Sales by Region (2024-2029) & (K Units)
Table 97. Middle East, Africa and Latin America Human Insulin Drugs Sales by Type (2018-2024) & (K Units)
Table 98. Middle East, Africa and Latin America Human Insulin Drugs Sales by Type (2024-2029) & (K Units)
Table 99. Middle East, Africa and Latin America Human Insulin Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 100. Middle East, Africa and Latin America Human Insulin Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 101. Middle East, Africa and Latin America Human Insulin Drugs Sales by Application (2018-2024) & (K Units)
Table 102. Middle East, Africa and Latin America Human Insulin Drugs Sales by Application (2024-2029) & (K Units)
Table 103. Middle East, Africa and Latin America Human Insulin Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Human Insulin Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Human Insulin Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 106. Middle East, Africa and Latin America Human Insulin Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Human Insulin Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 108. Middle East, Africa and Latin America Human Insulin Drugs Sales by Country (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Human Insulin Drugs Sales by Country (2024-2029) & (K Units)
Table 110. Novo Nordisk Company Information
Table 111. Novo Nordisk Description and Major Businesses
Table 112. Novo Nordisk Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Novo Nordisk Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Novo Nordisk Recent Developments
Table 115. Sanofi Company Information
Table 116. Sanofi Description and Major Businesses
Table 117. Sanofi Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Sanofi Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Sanofi Recent Developments
Table 120. Eli Lilly Company Information
Table 121. Eli Lilly Description and Major Businesses
Table 122. Eli Lilly Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Eli Lilly Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Eli Lilly Recent Developments
Table 125. Biocon Company Information
Table 126. Biocon Description and Major Businesses
Table 127. Biocon Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. Biocon Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Biocon Recent Developments
Table 130. Pfizer Company Information
Table 131. Pfizer Description and Major Businesses
Table 132. Pfizer Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. Pfizer Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 134. Pfizer Recent Developments
Table 135. Wockhardt Company Information
Table 136. Wockhardt Description and Major Businesses
Table 137. Wockhardt Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 138. Wockhardt Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 139. Wockhardt Recent Developments
Table 140. Julphar Company Information
Table 141. Julphar Description and Major Businesses
Table 142. Julphar Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 143. Julphar Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 144. Julphar Recent Developments
Table 145. Exir Company Information
Table 146. Exir Description and Major Businesses
Table 147. Exir Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 148. Exir Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 149. Exir Recent Developments
Table 150. Sedico Company Information
Table 151. Sedico Description and Major Businesses
Table 152. Sedico Human Insulin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 153. Sedico Human Insulin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 154. Sedico Recent Developments
Table 155. Key Raw Materials Lists
Table 156. Raw Materials Key Suppliers Lists
Table 157. Human Insulin Drugs Distributors List
Table 158. Human Insulin Drugs Customers List
Table 159. Human Insulin Drugs Market Trends
Table 160. Human Insulin Drugs Market Drivers
Table 161. Human Insulin Drugs Market Challenges
Table 162. Human Insulin Drugs Market Restraints
Table 163. Research Programs/Design for This Report
Table 164. Key Data Information from Secondary Sources
Table 165. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Insulin Drugs Product Picture
Figure 2. Global Human Insulin Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Human Insulin Drugs Market Share by Type in 2022 & 2029
Figure 4. Basal or Long-acting Insulins Product Picture
Figure 5. Bolus or Fast-acting Insulins Product Picture
Figure 6. Traditional Human Insulins Product Picture
Figure 7. Combination Insulins Product Picture
Figure 8. Biosimilar Insulins Product Picture
Figure 9. Global Human Insulin Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 10. Global Human Insulin Drugs Market Share by Application in 2022 & 2029
Figure 11. Hospital
Figure 12. Household
Figure 13. Human Insulin Drugs Report Years Considered
Figure 14. Global Human Insulin Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Human Insulin Drugs Revenue 2018-2029 (US$ Million)
Figure 16. Global Human Insulin Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Human Insulin Drugs Revenue Market Share by Region (2018-2029)
Figure 18. Global Human Insulin Drugs Sales 2018-2029 ((K Units)
Figure 19. Global Human Insulin Drugs Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Human Insulin Drugs Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Human Insulin Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Human Insulin Drugs Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Human Insulin Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Human Insulin Drugs Sales YoY (2018-2029) & (K Units)
Figure 25. China Human Insulin Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Human Insulin Drugs Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Human Insulin Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Human Insulin Drugs Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Human Insulin Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Human Insulin Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Human Insulin Drugs in the World: Market Share by Human Insulin Drugs Revenue in 2022
Figure 32. Global Human Insulin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Human Insulin Drugs Sales Market Share by Type (2018-2029)
Figure 34. Global Human Insulin Drugs Revenue Market Share by Type (2018-2029)
Figure 35. Global Human Insulin Drugs Sales Market Share by Application (2018-2029)
Figure 36. Global Human Insulin Drugs Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Human Insulin Drugs Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Human Insulin Drugs Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Human Insulin Drugs Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Human Insulin Drugs Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Human Insulin Drugs Revenue Share by Country (2018-2029)
Figure 42. US & Canada Human Insulin Drugs Sales Share by Country (2018-2029)
Figure 43. U.S. Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Human Insulin Drugs Sales Market Share by Type (2018-2029)
Figure 46. Europe Human Insulin Drugs Revenue Market Share by Type (2018-2029)
Figure 47. Europe Human Insulin Drugs Sales Market Share by Application (2018-2029)
Figure 48. Europe Human Insulin Drugs Revenue Market Share by Application (2018-2029)
Figure 49. Europe Human Insulin Drugs Revenue Share by Country (2018-2029)
Figure 50. Europe Human Insulin Drugs Sales Share by Country (2018-2029)
Figure 51. Germany Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. France Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. China Human Insulin Drugs Sales Market Share by Type (2018-2029)
Figure 57. China Human Insulin Drugs Revenue Market Share by Type (2018-2029)
Figure 58. China Human Insulin Drugs Sales Market Share by Application (2018-2029)
Figure 59. China Human Insulin Drugs Revenue Market Share by Application (2018-2029)
Figure 60. Asia Human Insulin Drugs Sales Market Share by Type (2018-2029)
Figure 61. Asia Human Insulin Drugs Revenue Market Share by Type (2018-2029)
Figure 62. Asia Human Insulin Drugs Sales Market Share by Application (2018-2029)
Figure 63. Asia Human Insulin Drugs Revenue Market Share by Application (2018-2029)
Figure 64. Asia Human Insulin Drugs Revenue Share by Region (2018-2029)
Figure 65. Asia Human Insulin Drugs Sales Share by Region (2018-2029)
Figure 66. Japan Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 70. India Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Human Insulin Drugs Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Human Insulin Drugs Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Human Insulin Drugs Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Human Insulin Drugs Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Human Insulin Drugs Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Human Insulin Drugs Sales Share by Country (2018-2029)
Figure 77. Brazil Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Human Insulin Drugs Revenue (2018-2029) & (US$ Million)
Figure 82. Human Insulin Drugs Value Chain
Figure 83. Human Insulin Drugs Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries